Several studies have shown that the AGEs-RAGE pathway plays vital roles in the progression of various kidney disorders including hypertensive nephropathy, diabetic nephropathy, lupus nephritis, obesity-related glomerulopathy, amyloidosis, ADPKD, and septic AKI [32–39]. Here, AGER is linked to hypertensive nephropathy.